Warburg Pincus

Warburg Pincus is a prominent private equity and venture capital firm based in New York, established in 1966. The firm specializes in investing across all stages of a company's lifecycle, from startups to mature businesses, and engages in various investment strategies including growth equity, management buyouts, and special situations. With over $45 billion in assets under management, Warburg Pincus maintains a diverse portfolio of more than 165 companies globally. The firm targets investments in sectors such as energy, financial services, healthcare, consumer products, technology, and real estate, with a focus on acquiring undervalued and middle-market companies. It typically invests between $20 million and $1 billion and seeks to partner with management teams to build sustainable value. Warburg Pincus has raised 17 private equity funds and has invested over $68 billion across more than 825 companies in over 40 countries, reflecting its extensive experience and global reach. The firm's operations are supported by offices in various major cities worldwide.

Issam Abedin

VP

Samantha Ackerman

Associate, Fundraising and Investor Relations

Saurabh Agarwal

Managing Director & Head of Southeast Asia Private Equity

Jonas Agesand

Partner and Managing Director, Fundraising and Investor Relations

Ankit Aggarwal

Associate

Gregory Baecher

Managing Director, Fundraising and Investor Relations

Carl von Baumbach

Vice President

Christopher Beattie

Associate Director, Communications

Simon Begg

Director, Portfolio

Mark Begor

Managing Director and Operating Partner of Industrial and Business Services

Cem Behmoaram

Vice President of Healthcare and Consumer

Alain J. P. Belda

Managing Director

Roy Ben-Dor

Managing Director

Alex Berzofsky

Managing Director, Technology, Media and Telecommunications

Alexander Eric Berzofsky

MD

Damon Beyer

Managing Director

Atticus Bieff

Associate

Owen R. Boger

Principal, Fundraising and Investor Relations

Rob Buonanno

Managing Director

Maximilian Buttinger

Associate

Wei Cao

Principal

Sean D. Carney

Managing Director

Richard Chan

Executive Director

Brian Chang

Managing Director

Sarah Chen

Director

Ruoxi Chen

Managing Director

Julian Cheng

Managing Director and Co-head of China

Vikram Chogle

Vice President

Alex Chun

Vice President

Enzo Ciantelli

Vice President

Mark Colodny

Managing Director, Co-Head of U.S. Private Equity, Head of Technology and Member of the Executive Management Group

David A. Coulter

Vice Chairman

Timothy J. Curt

Managing Director of Finance

Cary J. Davis

Managing Director, Technology Investments

Peter Deming

Managing Director

Harjot Dhaliwal

Vice President

Aditya Dhawan

Investment Professional

Gordon Ding

Partner and Managing Director

Stephen A. Distler

MD

Nevio Duci

Vice President

Martin D. Dunnett

MD

Tony Eales

Managing Director

Li Fan

Managing Director, Real Estate

Min Fang

MD

Silvia Feng

Associate Director, Communications

Andrew Fitzpatrick

Vice President

Julie Foster

European Communications Director

Max Fowinkel

Managing Director

Eric Friedman

Managing Director

Frances Fukuda

SVP

Joseph Gagnon

Managing Director

Timothy Geithner

President

Jan-Ole Gerschefski

Vice President

Stephanie Geveda

Principal

Steven Glenn

Managing Director, CFO

Yen Goh

Senior Vice President

Jeffrey Goldfaden

Managing Director

Michael S. Graff

Managing Director

Greta Gu

Investment Manager

Christopher Gunther

Managing Director, Fundraising and Investor Relations

Parag Gupta

Vice President

Patrick T. Hackett

Special Limited Partner

Fred Hassan

Partner and Managing Director

Youn Hong

Director, Fundraising and Investor Relations

Eddie Huang

Managing Director, Fundraising and Investor Relations

In Seon Hwang

Managing Director

Faisal Jamil

Managing Director, Fundraising and Investor Relations

Pao Jirakulpattan

Associate

Peter R. Kagan

Managing Director

Sandeep Kagzi

Vice President

Daniel Kanak

Executive Director, Fundraising and Investor Relations

Jonathan Kane

VP

Charles R. Kaye

Co-Chief Executive Officer

Chip Kaye

Chief Executive Officer

Robert B. Knauss

Managing Director

Adam Krainson

Vice President

Henry Kressel

Managing Director

Amr Kronfol

Managing Director

Kanika Kumar

Director, Fundraising and Investor Relations

Raj Kushwaha

Chief Technology Officer and Managing Director

Joseph Landy

Co-Chief Executive Officer

Zachary Lazar

Principal

NIck Lee

VP

Terence Lee

Principal

Brandon Li

Vice President - Real Estate

Mingxia Li

Director, Communications

Vishal Mahadevia

Managing Director, Head of Asia Private Equity, Co-Head of Financial Services & Member of the Executive Management Group

Bruno Maimone

Principal

Niten Malhan

MD

Vishnu Menon

Managing Director

Piero Minardi

Managing Director and Head of Brazil

Hemant Mundra

Principal

Henrique Muramoto

Managing Director

Douglas John Musicaro

Principal

Lucas Mussi

Vice President

Siddharth Narayan

Vice President

Nitin Nayar

Managing Director

James Neary

Managing Director, Co-Head of U.S. Private Equity & Member of the Executive Management Group

Himanshu Nema

Vice President

Ellen Ng

Managing Director

Lance Rue Odden

Advisor

Sina Oefinger

Vice President

Maximilian von Oppersdorff

Principal

Narendra Ostawal

Managing Director

Marcelo Otero

Associate

James O’Gara

Managing Director

Michael Pan

Vice President & Principal

Andrew Park

Managing Director

Henry Aaron Patner

Private Equity Associate

Jeffrey Perlman

Managing Director and Head of Southeast Asia

Flavio Porciani

Managing Director

Chandler Reedy

Managing Director

David Reis

Managing Director

Werner Rickinger

Associate

John Rowan

Managing Director

Eduardo Rubini

Associate

Justin Sadrian

Managing Director

Anish Saraf

Managing Director

Adarsh Sarma

Managing Director

Viraj Sawhney

Managing Director

Rianne Schipper

Vice President

Steven G. Schneider

Managing Director

Joseph C. Schull

MD

Tom Setiawan

Vice President

John Shearburn

Managing Director, Fundraising and Investor Relations

Chris Shen

Principal

Leo Shi

Managing Director

Swapnil Sinha

Principal

Kevin Soedyatmiko

Associate

Ashutosh Somani

Managing Director

Brian Spillane

Senior Vice President

David Sreter

Managing Director of Finance

Jeffrey Stein

Managing Director

Alex Stratoudakis

Managing Director

Luca Tajra

Associate

Barry E. Taylor

MD

Michael Thompson

Managing Director

Michael Twaddle

Vice President

Caroline Watteeuw

Director, IT Strategy and Assessment

Elizabeth H. Weatherman

Managing Director

Frank Wei

Managing Director and Co-head of China

James Wilson

Managing Director, Fundraising and Investor Relations

Roland Xu

Managing Director, CFO

Vera Yang

MD

Dan Zamlong

Managing Director

Jennifer Zhang

Principal

Qiqi Zhang

Managing Director

Jericho Zhang

Managing Director, Healthcare and Consumer sectors in China

Chloe Zhang

Vice President - Real Estate

Ben Zhou

Managing Director and Principal

Lilian Zhu

Managing Director

Daniel Zilberman

Managing Director

Lauren Zletz

VP

T. J. Carella

Managing Director

Past deals in Hong Kong

Insilico Medicine

Series D in 2022
Insilico Medicine, Inc. is an artificial intelligence company based in Rockville, Maryland, specializing in drug discovery, biomarker development, and aging research. Founded in 2014, the company leverages advanced AI techniques, including generative adversarial networks and deep learning, to create novel molecular structures for various diseases. Insilico Medicine has developed a comprehensive end-to-end pipeline for drug discovery, which encompasses all stages from initial research to clinical trials. Its notable platforms include Pharma.AI, which offers machine learning services to various sectors, and Young.AI, which integrates predictors of age. The company is actively engaged in internal drug discovery programs targeting conditions such as cancer, Alzheimer's disease, and diabetes. Additionally, Insilico Medicine has partnered with Life Extension to produce nutraceutical products using bioinformatics and deep learning. It serves a diverse clientele, including academia, pharmaceutical companies, and cosmetic firms, while also providing consumer-facing applications to enhance health and longevity.

Insilico Medicine

Series C in 2021
Insilico Medicine, Inc. is an artificial intelligence company based in Rockville, Maryland, specializing in drug discovery, biomarker development, and aging research. Founded in 2014, the company leverages advanced AI techniques, including generative adversarial networks and deep learning, to create novel molecular structures for various diseases. Insilico Medicine has developed a comprehensive end-to-end pipeline for drug discovery, which encompasses all stages from initial research to clinical trials. Its notable platforms include Pharma.AI, which offers machine learning services to various sectors, and Young.AI, which integrates predictors of age. The company is actively engaged in internal drug discovery programs targeting conditions such as cancer, Alzheimer's disease, and diabetes. Additionally, Insilico Medicine has partnered with Life Extension to produce nutraceutical products using bioinformatics and deep learning. It serves a diverse clientele, including academia, pharmaceutical companies, and cosmetic firms, while also providing consumer-facing applications to enhance health and longevity.

DaDa

Series D in 2019
Founded in 2013, DaDa is the most innovative online English training institution in China, and was established to provide what has become one of China’s most successful intelligent English learning platforms for children aged 5 to 16. Winner of over 15 awards and recognitions such as ‘Sina Five-Star Golden Foreign Teacher Award ', 'One of the 50 Business Starters in Shanghai', 'Top 20 among online teaching of China',The Most Growing Value Award and The Best Youth Model Award in 2016 ,Tencent Education the most creditable children’s English brand in 2015. DaDa developed a leading English training system focused on one-on-one online tutoring and encourage youngsters to learn and practice while having fun with instructors. DaDa has a myriad of famous investors such as Qingsong Fund, Feima Fund, Dragonrise Capital and Yonghua Capital and announced a total capital raising of 500 million RMB in Series B and Series B+, which will be used in market expansion, curriculum development and learning experience improvement. DaDa has been helping students from mainland China, Hong Kong, Taiwan, South Korea, Japan, France, Germany, and other non-English speaking countries. More importantly, we are working towards "empowering their children to achieve more".

Weave Living

Series A in 2018
Weave Living is a collaborative living company that creates residential communities in major cities across the Asia Pacific region. The company is a new way of hassle-free, value-for-money accommodation for urban young professionals.Their mission is to provide comfortable, convenient, and well-priced homes. Weave was founded in 2017 and is based in Hong Kong, Hong Kong.

AAG Energy Holdings

Series B in 2012
AAG Energy Holdings Limited engages in the exploration, development, production, and sale of coalbed methane in the People's Republic of China. It holds interests in the Panzhuang concession covering an area of 141.8 square kilometers in the southern area of Qinshui Basin; and the Mabi concession extending over an area of 898.2 square kilometers in the southern Qinshui Basin in Shanxi province under production sharing contracts. The company was founded in 1994 and is headquartered in Central, Hong Kong. AAG Energy Holdings Limited is a subsidiary of Liming Holding Limited.

Harbour Networks Holdings

Series C in 2005
Harbour Networks Holdings was acquired by Huawei Technologies Co. Ltd. The company provides Internet protocol-based networking equipment. The company offers Ethernet switches, IP core and edge routers, broadband access equipment, voice over Internet protocol products, optical transport platforms, and networking and services management software, as well as ADSL/VDSL broadband access equipment and NGN integrated access equipment. It serves telecom carriers, corporations, education and government institutions, government agencies, finance, power, and service industries in China, North America, Japan, Hong Kong, and Southeast Asia. The company was founded in 2000 and is based in Beijing, China. As of September 11, 2006, Harbour Networks Holdings Limited operates as a subsidiary of Huawei Technologies Co., Ltd.